MMJ (ASX: MMJ) has pleased its shareholders this morning by announcing that subsidiary cannabis company Harvest One had signed an MoU with the British Columbia Liquor Distribution Board (BC LDB) for the supply of recreational cannabis. Harvest One is to acquire PhytoTech Therapeutics from MMJ, subject to MMJ shareholder approval later this year. The company operates three distinct business units: United Greeneries, Satipharm and Dream Water and is solely focused on servicing both the medical and recreational cannabis markets, in Canada and internationally. Harvest One offers significant exposure to the entire cannabis value chain through three wholly owned operating subsidiaries: horticultural arm and Canadian Licensed Producer United Greeneries Ltd., medical and pharmaceutical arm Satipharm AG in Switzerland and Dream Water Global, the Group’s consumer goods division. Each business is strategically located in favourable jurisdictions with supportive regulatory frameworks in place and gearing up for legal recreational cannabis in Canada, to be finalised in the foreseeable future. MMJ announces timely recreational cannabis deal through Harvest One in Canada

thumbnail courtesy of